Dose Escalation TTHX1114 Ophthalmic Solution

NCT05769920 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Corneal Epithelial Degeneration

Interventions

DRUG: TTHX1114(NM141) Ophthalmic Solution

Sponsor

Trefoil Therapeutics, Inc.